Founded 2013 | ||
Tbwa paling walters epibone meet lions health tv
EpiBone is a biomedical engineering company that is currently in the process of reconstructing human bone growth for use in surgical operations. EpiBone will allow patients to grow bones with the use of their own stem cells in order to create a patient-specific product. These specialized bone grafts can simplify surgery, provide exact repair, and shorten recovery times. EpiBone has animal-tested its product and is currently waiting for FDA approval to begin testing with humans. It was created by its current CEO, Nina Tandon.
Contents
- Tbwa paling walters epibone meet lions health tv
- Talking clinical trials of the future with nina tandon epibone ceo ted senior fellow speaker
- Benefits
- Process of creation
- Progress
- Background
- References
Talking clinical trials of the future with nina tandon epibone ceo ted senior fellow speaker
Benefits
EpiBone can improve existing factors of surgery, including recovery times, foreign body implantation, regeneration, and bone repair accuracy. EpiBone can also lead to a decreased amount of surgeries possibly saving trillions of dollars per year.
Process of creation
With the use of technology, EpiBone is able to create a reconstructed bone graft. This process goes through five major steps which are: scanning the defect, collecting the stem cells, placing the cells into the bioreactor, and allowing the cells to develop and grow.
- CT Scan – EpiBone starts the bone reproduction process with a CT Scan. The patient will undergo this scan so EpiBone can receive a complete picture of the bone defect's exact size and shape.
- Stem Cells – EpiBone retrieves stem cells from the patient's fat tissue. EpiBone uses multipotent stem cells, which are capable of developing into multiple tissues and bone.
- Bioreactor – The mulitpotent stem cells are placed into a bioreactor, which simulates conditions inside the body. This allows the stem cells to begin growth. EpiBone uses the frames of animal bone and cartilage to influence the shape of which the stem cells grow. The bioreactor makes EpiBone have the potential to build patient-specific bone grafts for craniofacial and orthopedic reconstructions.
- Cell Development – The cells develop into a customized, living implant in three to four weeks. Cells naturally mature to form strength and shape.
Progress
So far, EpiBone has tested its product on pigs. They have tested on pigs because their head size and mechanics of chewing are similar to humans. EpiBone built a temporomandibular joint, a complex bone in the system of a jaw, to truly test how useful their productivity.
Background
Nina Tandon is the CEO and co-founder of EpiBone. She possesses ten years of experience in tissue engineering and over eight years of experience in bioreactor design. She attended Columbia University, MIT, and McKinsey. She possesses the goal to create an alternative for human implantation.